SAL003

· Shenzhen Salubris Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SAL003, covering 2025-11-28 to 2025-12-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SAL003 in Participants With Hypercholesterolemia and Mixed Dyslipidemia [Phase 3]